Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 5/2004

01-09-2004

Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study

Authors: Kazuhiro Kushida, Masataka Shiraki, Toshitaka Nakamura, Hideaki Kishimoto, Hirotoshi Morii, Kichizo Yamamoto, Kiyoshi Kaneda, Masao Fukunaga, Tetsuro Inoue, Mitsuyoshi Nakashima, Hajime Orimo

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2004

Login to get access
Metadata
Title
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study
Authors
Kazuhiro Kushida
Masataka Shiraki
Toshitaka Nakamura
Hideaki Kishimoto
Hirotoshi Morii
Kichizo Yamamoto
Kiyoshi Kaneda
Masao Fukunaga
Tetsuro Inoue
Mitsuyoshi Nakashima
Hajime Orimo
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2004
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-004-0508-0

Other articles of this Issue 5/2004

Journal of Bone and Mineral Metabolism 5/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine